Telesis Bio Q2 Adj $(7.62) Misses $(4.03) Estimate, Sales $1.55M Miss $6.50M Estimate
Author: Benzinga Newsdesk | August 07, 2024 04:45pm
Telesis Bio (NASDAQ:
TBIO) reported quarterly losses of $(7.62) per share which missed the analyst consensus estimate of $(4.03) by 89.08 percent. This is a 51.19 percent decrease over losses of $(5.04) per share from the same period last year. The company reported quarterly sales of $1.55 million which missed the analyst consensus estimate of $6.50 million by 76.15 percent. This is a 82.09 percent decrease over sales of $8.65 million the same period last year.
Posted In: TBIO